Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN104418775B details palladium-catalyzed asymmetric hydrogenolysis for high-purity chiral amine production offering significant supply chain and cost advantages.
Patent CN104803898A enables mild visible light catalysis for aryl sulfides. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN107641100A details a mild copper-catalyzed route for 6-cyanophenanthridine. This method offers significant supply chain stability and cost advantages for pharmaceutical manufacturing.
Patent CN107383005B reveals a green one-step synthesis for high-purity Zolpidem intermediates, offering significant cost reduction and scalable manufacturing solutions.
Patent CN110698451A reveals a novel P2O5 cyclization method for Baloxavir intermediates. Achieve high purity, low waste, and cost reduction in API manufacturing.
Patent CN1974567B details a safer, scalable synthesis of Sertaconazole Nitrate using NaOH/Isopropanol, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel 4-step synthesis of Idelalisib eliminates metal residues and reduces costs. Ideal for reliable API intermediate suppliers seeking green manufacturing.
Patent CN104592222B reveals a cost-effective AZD6482 route using chiral sulfinamide. Enhance supply chain reliability and reduce manufacturing costs significantly.
Patent CN113336792B reveals a novel Lewis acid-catalyzed synthesis for cyclic phosphonate compounds, offering superior stereoselectivity and scalable manufacturing for NASH therapeutics.
Patent CN104557737B details a high-yield Pd-catalyzed route for quinazoline intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel copper-catalyzed route for polyaryl sulfone intermediates offers safer processing and significant cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN110922305A reveals a novel route for 5-bromo-2-chloro-4'-ethoxy diphenylmethane, eliminating ortho-impurities and ensuring high-purity API intermediates.
Novel room-temperature mesylation route for Ertapenem side chain. Reduces cryogenic costs and simplifies purification for scalable API manufacturing.
Patent CN107880046B details a CSA-catalyzed route for dibenzo azepines offering high yields and simplified processing for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN118028403A reveals high-purity NMN synthesis via immobilized enzyme. Offers significant cost reduction and supply chain reliability for nutraceutical manufacturers.
Patent CN109136311B reveals cost-effective SAM production. Adenosine substrate replaces ATP. Reliable supplier for pharma intermediates.
Novel supported catalyst method improves yield and purity for folic acid production. Reduces reaction time and enhances supply chain reliability for global buyers.
Novel organofluorine-mediated synthesis of 2,3-unsaturated glycosides with high alpha-selectivity. Reduces heavy metal use and enables catalyst recycling for cost-effective API intermediate manufacturing.
Patent CN103435688A reveals a novel high-yield route for Phosphoramidone and Tarotide intermediates, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN105801337B details a novel Pd-Cu catalytic route for phenanthrene compounds offering high purity and scalable manufacturing for global supply chains.